Favourable outcome in 33 triplet pregnancies managed between 1985-1990.
In this paper, we describe the outcome of 33 triplet pregnancies referred to us between 1985 and 1990. They were managed as follows: management at home as soon as the diagnosis was made, then hospitalization at 28 weeks' gestation. Progesterone and beta-mimetics were administered daily, a cesarean section was always performed. One late abortion occurred at 21 weeks. The rate of prematurity was 90.6%, mean gestational age at delivery was 34.1 +/- 3 weeks, and 62.5% of deliveries occurred between 34 and 37 weeks. Ninety-four fetuses were delivered alive. Mean birth weight was 1880 +/- 410 g. Fetal growth retardation rate was 61.8%, including 28 infants under the third centile and 31 under the 10th centile. Perinatal death rate was 4.16% including 2 in utero deaths and 2 neonate deaths. All infants are healthy except for one child with severe mental retardation. These results show that triplet pregnancies can be safely managed, and that selective first-trimester reduction in triplet pregnancies does not appear to be necessary.
Boulot
P
P
Department of Obstetrics and Gynecology and Montpellier-Nimes University of Medicine, France.
Hedon
B
B
Pelliccia
G
G
Sarda
P
P
Montoya
F
F
Mares
P
P
Humeau
C
C
Arnal
F
F
Laffargue
F
F
Viala
J L
JL
D000328:Adult; D000420:Albuterol / Q000627:therapeutic use; D001724:Birth Weight; D002585:Cesarean Section; D005260:Female; D005313:Fetal Death; D006801:Humans; D007501:Iron / Q000627:therapeutic use; D002955:Leucovorin / Q000627:therapeutic use; D007752:Obstetric Labor, Premature / Q000188:drug therapy; D011247:Pregnancy; D011248:Pregnancy Complications; D011256:Pregnancy Outcome; D011272:Pregnancy, Multiple; D011295:Prenatal Care / Q000379:methods*; D011374:Progesterone / Q000627:therapeutic use; D014310:Triplets
D011374:Progesterone; D007501:Iron; D002955:Leucovorin; D000420:Albuterol